Arisaph preclinical data

In healthy mice, ARI-2243, a dipeptidyl peptidase-4 (DPP-4) inhibitor, lowered plasma glucose levels further than Januvia sitagliptin, an approved DPP-4 inhibitor from Merck & Co. Inc. (MRK, Whiteh...